- Changan Auto reported vehicle sales of 284,197 units in November 2025.
- This is a 2.5% increase compared to November of the previous year, where sales were 277,298 units.
- Year-to-date vehicle sales reached 2.66 million units, reflecting a 9.3% increase from the previous year.
- Analyst recommendations include 22 “Buy” ratings and 5 “Hold” ratings, with no “Sell” ratings.
- All comparisons are made against the company’s originally disclosed figures.
“`
A look at Chongqing Changan Automobile Company Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Chongqing Changan Automobile Company Limited, a company that specializes in developing, manufacturing, and marketing mini cars, mini sedans, full-size sedans, and engines, is showing a positive long-term outlook based on the Smartkarma Smart Scores. With high scores in both Value and Dividend, the company is evidently solid in terms of its financial stability and returns to shareholders. Additionally, scoring well in Resilience indicates a strong ability to weather market challenges. However, there is room for improvement in Growth and Momentum scores, suggesting potential areas for the company to focus on enhancing its performance over time.
In summary, Chongqing Changan Automobile Company Limited seems to be a strong player in the automotive industry, offering value to investors through both solid financials and dividend payouts. Despite moderate scores in Growth and Momentum, the company’s resilience and overall positive outlook suggest it remains a promising investment option for those looking for stability and potential long-term returns.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
